Coston McIsaac & Partners’s Exelixis EXEL Stock Holding History

Coston McIsaac & Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-130	Closed	-$2K	–	783
2023 Q1	$2K	Buy	+130	New	+$2.27K	﹤0.01%	688

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Coston McIsaac & Partners's EXEL Position: Q2 2023 in Review

Coston McIsaac & Partners sold out of Exelixis (EXEL) in Q2 2023, closing a stake of 130 shares — an estimated $2K sold.

Coston McIsaac & Partners first reported a position in EXEL in Q1 2023 and held it in 1 quarter. The position peaked at $2K in Q1 2023. 378 funds tracked by Wall St. Rank hold EXEL as of Q2 2023.

Coston McIsaac & Partners reported no remaining Exelixis position as of Q2 2023 after selling out during the quarter.
Coston McIsaac & Partners sold 130 Exelixis shares in Q2 2023, an estimated $2K.
Coston McIsaac & Partners first reported a position in Exelixis in Q1 2023 and held it in 1 quarter.
Coston McIsaac & Partners's Exelixis position peaked at $2K in Q1 2023.
378 funds tracked by Wall St. Rank held Exelixis as of Q2 2023.

Based on Coston McIsaac & Partners's 13F filing for Q2 2023, filed 1 Aug 2023.